Decision of Anticoagulation in Nonvalvular Atrial Fibrillation in the Real World in the Non-Antivitamin K Anticoagulants Era

Background. Patients with nonvalvular atrial fibrillation (NVAF) have five times higher risk of stroke than the general population. Anticoagulation (ACO) in NVAF is a class I indication after assessing the CHA2DS2-VASc and HAS-BLED scores. However, in the real world, NVAF patients receive less ACO t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gheorghe, Gabriela Silvia, Hodorogea, Andreea Simona, Gheorghe, Andrei Cristian Dan, Popa, Dragoș Emanuel, Vulpe, Simona, Georgescu, Cristina, Bănică, Ruxandra, Florescu, Andrei Gorgian, Trușcă, Elena Cristiana, Eden, Omer, Ciobanu, Ana, Pârvu, Irina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317193/
https://www.ncbi.nlm.nih.gov/pubmed/35885863
http://dx.doi.org/10.3390/healthcare10071333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317193/
https://www.ncbi.nlm.nih.gov/pubmed/35885863
http://dx.doi.org/10.3390/healthcare10071333

Ejemplares similares